Showing 531 articles

  • Oxurion NV appoints Grace Chang, M.D., Ph.D. as Chief Medical Officer

    6 Aug 2020| Nola Cadman

    Oxurion (Euronext Brussels: OXUR) is a biopharmaceutical company developing next generation ophthalmic therapies which are designed to better preserve vision in patients with diabetic macular edema (DME), the leading cause of vision loss in diabetic patients worldwide.

  • Top Pharma Companies Hiring In August, 2020

    31 Jul 2020| Nola Cadman

    Top Pharma Companies Hiring In August, 2020

  • Top Pharma Recruiters Advertising in August, 2020

    31 Jul 2020| Nola Cadman

    Here's a list of the top pharma and life science recruitment companies advertising in August on PharmiWeb.jobs

  • CGT Catapult appoints Dr Sharon Brownlow as Chief Business Officer

    31 Jul 2020| Nola Cadman

    Sharon brings to the role her expertise in strategic and commercial leadership and enabling collaboration in the cell and gene therapy industry.

  • GAMA Healthcare Bolsters Science and Innovation Team with Four New Hires

    31 Jul 2020| Nola Cadman

    Headhunted expertise from Global FMCGs Reckitt Benckiser (RB) and Unilever to support increase in business and consumer demand for GAMA Healthcare’s innovative infection prevention and control products and education.

  • Alentis Therapeutics Names Roberto Iacone CEO

    31 Jul 2020| Nola Cadman

    Alentis Therapeutics, the Swiss-based biotech company focused on developing breakthrough treatments for fibrotic diseases, was founded in 2019 based on ground-breaking research in the laboratory of Prof. Thomas Baumert, MD at the University of Strasbourg.

  • Genespire appoints Jörn Aldag as Chairman of the Board of Directors

    31 Jul 2020

    Genespire is a biotechnology company focused on the development of transformative gene therapies for patients affected by genetic diseases, particularly primary immunodeficiencies and inherited metabolic diseases. Based in Milan, Italy, Genespire was founded in March 2020 by the gene therapy pioneer Prof. Luigi Naldini and Dr. Alessio Cantore, Fondazione Telethon and Ospedale San Raffaele.

  • Appointment of Chief Medical Officer at Moberg Pharma

    31 Jul 2020| Nola Cadman

    Moberg Pharma AB (publ) is a Swedish pharmaceutical company focused on commercializing proprietary innovations based on drug delivery of proven compounds. The company’s main asset, MOB-015, is a novel topical treatment for onychomycosis, with recently completed phase 3 trials in more than 800 patients.

  • What Does a Health Economist Do?

    29 Jul 2020| PharmiWeb Editor

    Health economics is one of those rapidly growing fields that links up business with health care. A health economist has a unique passion for using their knowledge of economics by applying it to a variety of challenges in health and medicine. As the population continues to grow, the demand for quality and cost-effective health care similarly grows, leaving careers in health economics vital to sustaining our health care system

  • Chair Appointed To Lead NHS Drive To Reduce Health Inequalities

    28 Jul 2020| PharmiWeb Editor

    A longstanding health leader and advocate on inequalities has been chosen to head up the health service’s major new work programme into the impact of race and ethnicity on people’s health, NHS chief executive Sir Simon Stevens has announced today at NHS England and NHS Improvement’s public board meeting.

  • Why should you treat your social environment mindfully?

    24 Jul 2020| Masha Ovechkina

    Let's talk about the ecology of your social environment, and how corporate culture influences the ways that employees can achieve success and well-being.

  • How Covid-19 is changing Job Seekers' Behaviours

    24 Jul 2020| Masha Ovechkina

    Unemployment rates across the globe have dramatically risen, yet despite that, so many countries have chosen to ignore COVID and do their best to recover economically.

  • Innate Pharma announces new Executive Vice President and Chief Medical Officer

    23 Jul 2020| Nola Cadman

    For Dr Dodion, this marks the end of a tenure with company that began back in 2014. Following his retirement, he will transition to a consulting role at the company.

  • Syneos Health appoints trio of senior hires

    23 Jul 2020| Nola Cadman

    Syneos president of communications Tim Pantello has bolstered the senior leadership team, which includes Syneos Health veterans Sonja Foster-Storch and Lisa Stockman

  • Onyx Health Expands with New Management Appointment

    23 Jul 2020| Nola Cadman

    Founded in 2003, by Managing Director Karen Winterhalter, Onyx Health is a Newcastle based healthcare marketing communications agency, working with life sciences, pharmaceutical and medical technology companies.

  • Acumentice expands senior team with Purdy appointment

    21 Jul 2020| Mike Wood

    Acumentice, one of the UK's leading healthcare management consultancies, has announced the appointment of Philip Purdy to build on its existing reputation for providing high-quality support to the NHS.

  • Davide Molho, DVM Joins Viroclinics Biosciences as Chief Executive Officer

    21 Jul 2020| Mike Wood

    ROTTERDAM, Netherlands, July 20, 2020 /PRNewswire/ -- Viroclinics Biosciences B.V. ("Viroclinics") today announced the appointment of life sciences industry veteran Davide Molho, DVM as the company's new Chief Executive Officer. Dr. Molho succeeds Bob van Gemen, PhD who has served as the company's CEO since 2011. This transition is part of a planned succession strategy. Dr. Molho's appointment will take effect on 1 August 2020.

  • Dr Edwin Moses appointed as Chairman of the Board of Sensorin

    17 Jul 2020| Nola Cadman

    Moses joins from his previous role as Chief Executive Officer of Ablynx and brings 25 years of experience at the top level of life science companies. He was in his role at Ablynx for 14 years and drove its growth, which led to it being acquired by Sanofi in 2018.

  • Hansa Biopharma expands the leadership team with the appointment of Katja Margell as new Head of Corporate Communications

    17 Jul 2020| Pharmiweb editor

    With the appointment of Katja Margell as new Head of Corporate Communications Hansa Biopharma seeks to strengthen its communication efforts internally as well as with media and external stakeholders as the Company transitions into a commercial stage biopharmaceutical company

  • Arcinova appoints new Non-Executive Director

    17 Jul 2020| Nola Cadman

    Internationally renowned Industry veteran Steve Bagshaw joins Arcinova board to propel continued industry-leading growth.